155 related articles for article (PubMed ID: 11779295)
21. [Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic study].
Sang W; Wang CF; Cheng YF; Liu X; Li XX; Gulinar A; Li JZ; Zhang W
Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):326-30. PubMed ID: 22883672
[TBL] [Abstract][Full Text] [Related]
22. Primary NK/T cell lymphoma of the testis. A case report and review of the literature.
Kim YB; Chang SK; Yang WI; Hahn JS; Koom WS; Shim SJ; Park W; Lee KK; Suh CO; Kim GE
Acta Haematol; 2003; 109(2):95-100. PubMed ID: 12624494
[TBL] [Abstract][Full Text] [Related]
23. Natural killer cell neoplasms.
Tse E; Liang RH
Clin Lymphoma; 2004 Dec; 5(3):197-201. PubMed ID: 15636697
[TBL] [Abstract][Full Text] [Related]
24. Extranodal natural killer/T-cell lymphoma in Malawi: a report of three cases.
Tomoka T; Powers E; van der Gronde T; Amuquandoh A; Dhungel BM; Kampani C; Kamiza S; Montgomery ND; Fedoriw Y; Gopal S
BMC Cancer; 2017 Sep; 17(1):633. PubMed ID: 28877678
[TBL] [Abstract][Full Text] [Related]
25. A hybrid form of myeloid/NK-cell acute leukemia and myeloid/NK-cell precursor acute leukemia.
Sun T; Pashaei S; Jaffrey I; Ryder J
Hum Pathol; 2003 May; 34(5):504-8. PubMed ID: 12792926
[TBL] [Abstract][Full Text] [Related]
26. Blastoid NK cell leukemia/lymphoma with cutaneous involvement.
Ginarte M; Abalde MT; Peteiro C; Fraga M; Alonso N; Toribio J
Dermatology; 2000; 201(3):268-71. PubMed ID: 11096204
[TBL] [Abstract][Full Text] [Related]
27. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
[TBL] [Abstract][Full Text] [Related]
28. Bone marrow involvement by nasal NK cell lymphoma at diagnosis is uncommon.
Wong KF; Chan JK; Cheung MM; So JC
Am J Clin Pathol; 2001 Feb; 115(2):266-70. PubMed ID: 11211616
[TBL] [Abstract][Full Text] [Related]
29. Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement.
Suzuki R; Nakamura S; Suzumiya J; Ichimura K; Ichikawa M; Ogata K; Kura Y; Aikawa K; Teshima H; Sako M; Kojima H; Nishio M; Yoshino T; Sugimori H; Kawa K; Oshimi K;
Cancer; 2005 Sep; 104(5):1022-31. PubMed ID: 15999368
[TBL] [Abstract][Full Text] [Related]
30. Blastic natural killer (NK) cell leukemia (agranular CD4+CD56+ leukemia).
Zhang K; Prichard JW; Brown RE
Ann Clin Lab Sci; 2006; 36(2):212-5. PubMed ID: 16682521
[TBL] [Abstract][Full Text] [Related]
31. Rapid leukaemic evolution in a cutaneous blastic NK-cell lymphoma initially diagnosed as pseudolymphoma.
Di Mario A; Garzia M; d'Alò F; Rumi C; Massini G; Bellesi S; Zini G
Hematology; 2007 Apr; 12(2):155-7. PubMed ID: 17454197
[No Abstract] [Full Text] [Related]
32. Blastic CD4 NK cell leukemia/lymphoma: a distinct clinical entity.
Falcão RP; Garcia AB; Marques MG; Simões BP; Fonseca BA; Rodrigues ML; Foss NT
Leuk Res; 2002 Sep; 26(9):803-7. PubMed ID: 12127554
[TBL] [Abstract][Full Text] [Related]
33. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia.
Khoury JD; Medeiros LJ; Manning JT; Sulak LE; Bueso-Ramos C; Jones D
Cancer; 2002 May; 94(9):2401-8. PubMed ID: 12015765
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.
Ozsan N; Cagirgan S; Saydam G; Gunes A; Hekimgil M
Pathol Res Pract; 2013 Aug; 209(8):471-8. PubMed ID: 23726928
[TBL] [Abstract][Full Text] [Related]
35. Agranular CD4+CD56+ blastic natural killer leukemia/lymphoma.
Kimura S; Kakazu N; Kuroda J; Akaogi T; Hayashi H; Nishida K; Abe T
Ann Hematol; 2001 Apr; 80(4):228-31. PubMed ID: 11401089
[TBL] [Abstract][Full Text] [Related]
36. Blastic natural killer (NK)-cell lymphoma: report of an unusual CD4 negative case and review of the CD4 negative neoplasms with blastic features in the literature.
Argyrakos T; Rontogianni D; Karmiris T; Kapsimali V; Grigoriou E; Tsantekidou M; Naum C; Galani V; Pantelidaki C; Harhalakis N; Nikiforakis E; Kanavaros P
Leuk Lymphoma; 2004 Oct; 45(10):2127-33. PubMed ID: 15370260
[TBL] [Abstract][Full Text] [Related]
37. [Iatrogenic immunodeficiency-associated Epstein-Barr virus (EBV) -negative natural killer cell lymphoproliferative disorder in a patient undergoing rheumatoid arthritis therapy].
Uchida T; Inoue M; Hua J; Tajima S; Ota Y; Hagihara M
Rinsho Ketsueki; 2017; 58(6):624-629. PubMed ID: 28679993
[TBL] [Abstract][Full Text] [Related]
38. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement.
Kato N; Yasukawa K; Onozuka T; Kikuta H
J Am Acad Dermatol; 1999 May; 40(5 Pt 2):850-6. PubMed ID: 10321634
[TBL] [Abstract][Full Text] [Related]
39. CD56-negative extranodal nasal type of natural killer/T-cell lymphoma with extranasal skin involvement.
Lan MX; Zhen ZX; Ming WH
Leuk Lymphoma; 2009 Oct; 50(10):1715-7. PubMed ID: 19863343
[No Abstract] [Full Text] [Related]
40. Acute T-lymphoblastic leukemia relapsed with the character of myeloid/natural killer cell precursor phenotype: a case report.
Hashimoto S; Toba K; Aoki S; Tsuchiyama J; Tsukada N; Takahashi H; Takahashi M; Aizawa Y
Leuk Res; 2002 Feb; 26(2):215-9. PubMed ID: 11755472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
